Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana.
Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, Indiana.
Am J Physiol Endocrinol Metab. 2021 Sep 1;321(3):E410-E416. doi: 10.1152/ajpendo.00151.2021. Epub 2021 Aug 2.
Type 1 diabetes is an insulin-dependent, autoimmune disease where the pancreatic β cells are destroyed resulting in hyperglycemia. This multifactorial disease involves multiple environmental and genetic factors, and has no clear etiology. Accumulating evidence suggests that early signaling defects within the β cells may promote a change in the local immune milieu leading to autoimmunity. Therefore, many studies have been focused on intrinsic β-cell mechanisms that aid in the restoration of cellular homeostasis under environmental conditions that cause dysfunction. One of these intrinsic mechanisms to promote homeostasis is autophagy, defects which are clearly linked with β-cell dysfunction in the context of type 2 diabetes. Recent studies have now also pointed towards β-cell autophagy defects in the context of type 1 diabetes. In this perspectives review, we will discuss the evidence supporting a role for β-cell autophagy in the pathogenesis of type 1 diabetes, including a potential role for unconventional secretion of autophagosomes/lysosomes in the changing dialogue between the β cell and immune cells.
1 型糖尿病是一种胰岛素依赖型、自身免疫性疾病,其中胰腺β细胞被破坏导致高血糖。这种多因素疾病涉及多种环境和遗传因素,病因尚不清楚。越来越多的证据表明,β细胞内早期信号缺陷可能会导致局部免疫环境发生变化,从而导致自身免疫。因此,许多研究都集中在内在的β细胞机制上,这些机制有助于在导致功能障碍的环境条件下恢复细胞内稳态。促进内稳态的内在机制之一是自噬,在 2 型糖尿病的背景下,自噬缺陷与β细胞功能障碍明显相关。最近的研究也指出了 1 型糖尿病中β细胞自噬缺陷的情况。在这篇观点综述中,我们将讨论支持β细胞自噬在 1 型糖尿病发病机制中的作用的证据,包括自噬体/溶酶体的非传统分泌在β细胞与免疫细胞之间不断变化的对话中的潜在作用。